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The protein component of the iron storage molecule, ferritin, contains 24 subunits in form of a hollow 
shell known as apoferritin. The amino acid sequence has been determined for apoferritin subunits from 
human liver. The sequence omprises 174 amino acids giving an it4* of 19 900. It shows extensive homology 
with the primary structures of apoferritins from human and horse spleen and from rat Iiver. Sequence 
substitutions are discussed in relation to the known three-dimensional structure of horse spleen apoferritin. 
Evidence for a second minor sequence in human liver apoferritin is presented. 
Human liver upoferritin 
1. INTRODUCTION 
Iron is an essential trace element in almost all 
living organisms. It is a constituent of many en- 
zymes (catalases, peroxidases, nitrogenases, hy- 
drogenases), electron transfer proteins (cyto- 
chromes) and oxygen carrier proteins (haemo- 
globin, myo~lobin). However, the solution chemis- 
try of iron has necessitated the development of 
specialised storage and transport systems. In 
aqueous media, at physiological pH, ferrous iron 
has a tendency to oxidise and hydrolyse forming 
polymeric hydrous ferric oxide or ‘ferrihydrite’ 
[I]. Intracellular iron storage therefore requires a 
specialised protein and this role is performed by 
ferritin. It consists of an iron core of ferrihydrite 
deposited in the cavity of a hollow protein shell 
(apoferritin), maintaining the iron in a stable, non- 
toxic and readily available store from which it can 
be mobilised when required. 
The protein shell consists of 24 structurally equi- 
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Amino acid sequence 
valent subunits f2] of two species differing slightly 
in size or apparent size as determined by SDS- 
polyacrylamide gel electrophoresis; the major or 
light subunit (L) with an M, of 19000 and the 
minor or heavy subunit (H) of Mr 21000 [3]. The 
relative proportions of the two subunits appear to 
be tissue specific [3]. The three-dimensional struc- 
ture of horse spleen apoferritin has been deter- 
mined and refined to 2.8 A; each subunit consisting 
of a paraBe bundle of 4 helices A-D with a 
smaller fifth helix perpendicular to them and an 
extended loop region connecting helices B and C 
I41. 
Studies on the primary structure of ferritins are 
of interest for several reasons: they assist in the 
identification of structural and functiona regions 
in the three-dimensional structure; form a com- 
parison with other ferritin sequences; and may 
provide a molecular explanation for the hetero- 
geneity of ferritin, i.e. the difference between H 
and L subunits. 
We present below the complete amino acid se- 
quence of the major subunit of human liver apofer- 
ritin and its comparison with the primary sequences 
of horse spleen [S], human spleen [6] and rat liver 
apoferritin f7J. We also report partial sequence 
data for a second minor sequence. 
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2. MATERIALS AND METHODS 
Ferritin from human liver was prepared by a 
modification of the procedure in [8] involving heat 
treatment, acidification to pH 4.8, ammonium sul- 
phate precipitation and high speed centrifugation 
at 100000 x g for 2 h. The purity of the prepara- 
tion was monitored by SDS-polyacrylamide gel 
electrophoresis and amino acid analysis. Samples 
were hydrolysed for 24 h in vacua with 6 N HCl 
(Aristar grade) at 105°C and analysis was perfor- 
med on a Locarte single column amino acid analy- 
ser (Locarte, London). 
Apoferritin was prepared by dialysis against 
0.1 M thioglycollic acid (Sigma, Poole) in 0.1 M 
sodium acetate solution at pH 4.25 and 4°C. Apo- 
ferritin was reduced [9] and carboxymethylated 
[lo] in 6 M guanidine hydrochloride prior to 
cleavage with trypsin, staphylococcal protease or 
Armillaria mellea protease [ 111. Trypsin and 
staphylococcal protease were also used to cleave 
carboxymethylated apoferritin, after citraconyla- 
tion of its lysine residues [ 121 in 6 M guanidine 
hydrochloride. 
A large A. Mellea protease peptide (AMI) of the 
N-terminal region of the sequence was further 
digested with chymotrypsin and staphylococcal 
protease. A large peptide TcIIIf from the citra- 
conylated tryptic digest was digested with trypsin 
after deblocking of the lysine residues by incuba- 
tion with 10% (v/v) acetic acid for 3 h at 45°C. 
Digests were initially separated by gel filtration 
on Sephadex G-SOSF and the smaller peptides ob- 
tained were purified by high voltage paper electro- 
phoresis at pH 2.0 and 6.5. Larger peptides were 
subjected to further gel filtration. The tryptic 
digest was initially fractionated by ion exchange 
chromatography on Dowex AG 5OWx2, followed 
by high voltage paper electrophoresis. 
Acid cleavage of carboxymethylated apoferritin 
in 70% (v/v) formic acid for 4 d at 37°C produced 
a single cleavage at the only Asp-Pro bond in the 
sequence [ 131 as previously seen in the horse spleen 
ferritin sequence [5]. Since ferritin is blocked [14] 
at its N-terminus, the free (Y-NH2 proline peptide 
present could be sequenced irectly by automatic 
liquid phase sequencing on a Beckman 890C spin- 
ning cup sequencer. One other large staphylococcal 
protease peptide SAcI, from the N-terminal re- 
gion, was sequenced by liquid phase sequence 
140 
analysis. The thiazolinones were converted to PTH 
amino acids and were identified by high pressure 
liquid chromatography. 
Smaller peptides were sequenced by the manual 
dansyl-Edman method [ 151, identifying the dansyl 
amino acids by thin layer chromatography on 
polyamide sheets [ 161. 
Purity of peptides was confirmed by dansyl 
N-terminal analysis [17] and amino acid analysis. 
Chemicals used in sequencing, sequencer or 
HPLC grade, were obtained from Pierce & 
Warriner (Chester) or Rathburn (Scotland). All 
other chemicals were AnalaR grade. Trypsin and 
chymotrypsin were from Miles (Slough). 
3. RESULTS 
The primary sequence of human liver apoferritin 
has been determined from peptides obtained from 
digests of the protein by trypsin, staphylococcal 
protease, A. mellea protease and from an acid 
cleavage. The sequence is presented in fig.1 with 
the peptides used to establish the sequence dis- 
played. Where no overlapping peptides were ob- 
tained, the homology, between the sequences of 
horse spleen and human spleen apoferritin, was 
utilised to place peptides in the sequence. 
A ninhydrin-negative, arginine-positive peptide 
TcIVNi, sequenced by mass spectrometry was 
identical to the N-terminal sequences of horse and 
human spleen apoferritins. 
Peptides obtained from a chymotryptic subdi- 
gest of the A. mellea protease peptide AM1 (resi- 
dues l-66 by amino acid analysis) overlapped with 
the N-terminal peptide and allowed continuation 
of the sequence up to Asn 17. 
The large staphylococcal protease peptide SAcI, 
sequenced by liquid phase sequence analysis, over- 
lapped with AM1 CH-bi and confirmed the se- 
quence up to Phe 35. Residues 36-39 have not 
been identified with certainty, but the amino acid 
analysis of the peptide is in good agreement with 
the residues proposed. 
Small tryptic peptides established the sequence 
from Asx 40 to Lys 97. Overlapping peptides were 
obtained for the region 47-66 from the staphylo- 
coccal protease subdigest of peptide AMI. Peptide 
TcIV(2), from the citraconylated tryptic digest, 
confirms the sequence between residues 65-72. 
The remaining peptides in this region were placed 
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AC SER SER GLN ILE ARG GLN ASN TYR SER THR ASP VAL GLU ALA ALA VAL ASN SER LEU VAL 
' AMICHd ’ AMICHbi 
I 
t 
TcIVNi 
t ‘SAcI 
30 40 
ASN LEU TYR LEU GLN ALA SER TYR THR TYR LEU(SER)LEU GLY PHEtTYR PHE ASX ARG)ASX 
- 
I~~~~~-~~-_~-_--~--~- 
SO 60 
ASX VAL ALA LEU GLU GLY VAL SER HIS PHE PHE ARG GLN LEU ALA GLU GLU LYS ARG GLU 
T7-13A 
_--_--_--_--_-4 
'T40-52B3 T30-35N4, TcIV(4)i 
-__-_-_--_-__-__--4 
’ AMISAIIc ’ AMISAIIh AMISAIIa ' 
70 80 
GLY TYR GLU ARG LEU LEU LYS MET GLN ASN GLN ARG GLY GLY ARG ALA LEU PHE GLN ASP 
1 
T26-29N3* T30-35B3B T26-29BlC T30-35B3B T23-25N2 
AMISAIIIe ' AMISAIIb ' 
'TcIV(2) 
I 
90 l@O 
ILE LYS LYS PRO ALA GLN ASP GLU TRP GLY LYS THR PRO ASP ALA MET LYS ALA ALA MET 
-' T40-52NlB 
--_---_----_-4 
’ T14-22N3B TcIIIfTIa 
I 
TcIIIf TIIo 
t + 
CB3A 
4 
110 120 
ALA LEU GLU LYS LYS LEU ASN GLN ALA LEU LEU ASP LEU HIS ALA LEU GLY SER ALA ARG 
1 . 
TcIIIf TIIc TcIIIf TIId 
I 
t 
TcIIIf TIINi 
1 
130 140 
THR ASP PRO HIS LEU CYS ASP PHE LEU GLU THR HIS PHE LEU ASP GLU GLU VAL LYS LEU 
, 
TAC 
i l--- 
l 
p2 
150 160 
ILE LYS LYS MET GLY ASP HIS LEU THR ASN LEU HIS ARG LEU GLY GLY PRO GLU ALA GLY 
___-__ 
TcIIIi! TIIa) T53-62BA 
170 
LEU GLY GLU TYR LBU PHE GLU ARG LEU THR LBU LYS HIS ASN 
_____________--_______~ 
T26-29B2E 
I 
' T14-22N4 
I 
TcIV(3) I 
Fig.1. Amino acid sequence of human liver apoferritin. Key to peptide naming: T, tryptic digest; Tc, citraconylated 
tryptic digest; AM, A. melleu protease digest; CH, chymotrypsin subdigest; SA, staphylococcal protease digest; CB, 
cyanogen bromide cleavage; P2, acid cleavage product; (-) sequence and amino acid analysis information; (------) 
amino acid analysis only. 
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by homology with the human and horse spleen 
sequences. 
Tryptic peptides extracted from a large citra- 
conylated tryptic fragment TcIIIf provided addi- 
tional sequence information for residues 100-120, 
with some overlaps being provided by a cyano- 
gen bromide peptide CB3A and tryptic peptide 
TcIIIf . TIINi. 
The sequence of the acid cleavage peptide Pz, 
determined by liquid phase sequence analysis, 
established the sequence from residues 123- 157. 
This region is confirmed by several tryptic pep- 
tides. 
The C-terminal sequence is provided by TcIV(S)- 
iii, from the citraconylated tryptic digest, from 
Leu 154 to Arg 168 and also overlaps with Pz. Two 
small tryptic peptides T 26-29 B2E and T 14-22 N4 
complete the sequence and are confirmed by pep- 
tide TcIV(3) from the citraconylated tryptic digest. 
4. DISCUSSION 
The M, of the apoferritin subunit, calculated 
from the sequence, is 19900, marginally lower 
than the value of 20017 for human spleen and 
slightly greater than that of 19824 for horse 
spleen. All these sequences contain a total of 174 
amino acids. Table 1 shows that the amino acid 
composition calculated from the sequence is in 
good agreement with values from amino acid 
analysis of apoferritin used in the sequence deter- 
mination. 
Fig.2 compares the apoferritin sequences of 
human liver, human spleen, horse spleen and rat 
liver and indicates the amino acid substitutions 
found. There are 23 substitutions between human 
liver and horse spleen apoferritins and 9 changes 
between human liver and human spleen. The rat 
liver sequence has 29 changes, plus an insertion of 
8 residues, when compared with the human liver 
sequence. 
Location of these changes on the three-dimen- 
sional structure of horse spleen apoferritin [18] 
shows the majority, including the 8 residue inser- 
tion, to be on the external surface of the molecule, 
i.e. on helices A (lo-39), C (92-120) and in the 
loop region (73-91) and are therefore easily accom- 
modated within the tertiary structure. There are 
few significant changes in the tightly packed hyd- 
rophobic regions of the helices, or in the critical 
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Table 1 
Amino acid composition of human liver apoferritin 
Amino acid 
Cys 
Asx 
Thr 
Ser 
Glx 
Pro 
Gly 
Ala 
Val 
Met 
Ile 
Leu 
T yr 
Phe 
His 
Trp 
Lys 
Arg 
Number of residues/subunit 
1 2 
1 1.8* 
19 20.9 
I 7.3 
8 9.1 
23 24.5 
4 4.1 
12 11.2 
15 14.3 
6 7.8 
4 3.8 
3 3.4 
27 26.0 
7 7.0 
8 1.0 
7 7.2 
1 0.8 
12 11.1 
10 8.9 
The amino acid composition is expressed as residues of 
each amino acid per subunit of M, 19900. Column 1 is 
calculated from the amino acid sequence and column 2 
from amino acid analysis of apoferritin used in the 
sequence determination. 
* Determination as carboxymethyl cysteine 
structural regions, involved in assembly or func- 
tion of the molecule. 
Only 3 substitutions (48,53 and 174) have occur- 
red on the internal surface of the molecule in 
human liver and cause no alteration to the overall 
structure. Two additional proline residues (93 and 
157) are found in the human liver sequence when 
compared with horse spleen. These changes occur 
at the beginning of helix C and in the DE turn 
respectively, positions where proline residues can 
be accommodated. 
Strongly conserved regions of the ferritin mole- 
cule are those around the 2-, 3- and 4-fold sym- 
metry axes. All the residues lining the 3- and 4-fold 
channels are conserved, with one exception Ser 13 1 
to Thr and this may be regarded as a conservative 
change. Many polar residues on the B helix near 
the 2-fold axis, which are disordered in the struc- 
ture, are conserved in all four sequences, i.e. 
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3) 
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5) 
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1) 
2) 
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4) 
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1) 
2) 
3) 
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7) 
10 20 30 
SSQIRQNYSTDVEAAVNSLVNLYLQASYTY 
Y Y 
n 
T P-n 
40 50 60 
L(S)LGF(YFBR)BBVALEGVSHFFRQLAEEKRE 
D(B Y)D T> 
n----D-~ c 
F-D-D c E 
-K 
--G--------E 
70 80 90 
GYERLLKMQNQRGGRALFQDIKKPAQDEWG 
m 
- LQ-----A 
-Y-E VQ---A 
1. 
100 110 120 
KTPDAMKAAMALEKKLNQALLDLHALGSAR 
T--IV P Q 
-LE 1" Q 
SGL-EC-L-VNQ-E 
130 140 150 
TDP.HLCDFLETHFLDEEVKLIKKMGDHLTN 
A c. 
r. c Y Y 
-E-V- 
- I Y---N-Q----E -- 
160 170 
LHRLGGPEAGLGEYLFERLTLKHN 
--fR K) D 
IQ-V-S .D 
-R-WQ-&--S D 
-R 
-R K M----A-- 
+ 
I t 
PAQTGVAQ 
Fig.2. Comparison of ferritin sequences. (1) Sequence of human liver apoferritin. (2) Sequence of human spleen 
apoferritin (61. (3) Sequence of horse spleen apoferritin [S]. (4) Sequence of rat liver apoferritin [7]. (5) Partial sequence 
of minor component of human liver apoferritin. (6) Partial sequence of minor component of human spleen apoferritin. 
(7) 8 residue insertion in rat liver apoferritin. 
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residues 52, 56, 57, 59, 60, 63 and 64. They may 
have a functional role in iron core nucleation [4], 
although not all these residues are conserved in the 
human liver cDNA sequence recently determined 
in [19]. 
Many substitutions have occurred in residues 
150-160, including the insertion in rat liver. This 
region is on the outer edge of the 4-fold channel, 
contrasting with the 3-fold channel where few 
changes have taken place. 
Four small peptides (yields 4-6070) were isolated 
and sequenced during the course of the human 
liver sequence determination (fig.2). They can be 
aligned with the major sequence, with some changes 
and may correspond to a minor sequence. These 
peptides have also been found in the human spleen 
sequence. The recent studies on cDNA of human 
liver apoferritin have established a sequence (43% 
differences in amino acid sequence) which encom- 
passes the minor sequence found in the human 
liver and spleen sequence determinations [ 191. 
Work on cDNA for the major subunit in rat liver 
ferritin has provided evidence in favour of separate 
mRNAs for the two subunits and the existence of 
a multigene family encoding for the major or light 
subunit [20]. This evidence concerning the origin 
of heterogeneity in tissue ferritins is accumulating 
in favour of H and L subunits being separate gene 
products from primary sequence studies and cloned 
DNA techniques. 
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